AngioDynamics (ANGO) closed the last trading session at $9.11, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

AngioDynamics delivered strong Q3 results, highlighting growth across its MedTech portfolio. With raised guidance and increasing adoption in key areas like Mechanical Thrombectomy and NanoKnife ...

H.C. Wainwright raised the firm’s price target on AngioDynamics (ANGO) to $16 from $15 and keeps a Buy rating on the shares. The company ...

Here is how AngioDynamics (ANGO) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year. The average of price targets set by Wall Street analysts indicates a ...

LATHAM, N.Y. (AP) — LATHAM, N.Y. (AP) — AngioDynamics Inc. (ANGO) on Wednesday reported a loss of $4.4 million in its fiscal third quarter. On a per-share basis, the Latham, New York-based ...

08:34 EDT AngioDynamics (ANGO) up 13% in pre-market at $10.90 after Q3 results, guidance raise Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment ...

Pulmonary embolism (PE) is a significant cause of morbidity and mortality, particularly in patients classified as acute, ...